Here, we demonstrate the value of T3 immunostaining, tissue clearing, and 3D imaging by mapping the pattern of expression of an immune checkpoint regulator, programmed cell death protein-ligand 1 (PD-L1), by both tumor and stromal cells in spontaneous mammary tumors formed in an MMTV-Her2/neu transgenic mouse model. This evidence concerns the gene ERBB2 and breast cancer.